INTRODUCTION: The ATP-binding cassette (ABC) transporters P-glycoprotein (P-gp/ABCB1), multidrug resistance-associated protein 1 (MRP1/ABCC1), and breast cancer resistance protein (BCRP/ABCG2) are known to transport a wide range of structurally diverse compounds. Their high level of expression at the blood-brain, maternal-fetal, and blood-testis barriers as well as their purported roles in oral absorption suggests that ABC transporters play important pharmacologic roles. METHODS: We have developed a method to characterize the function and inhibition of ABC transporters using an automated cell counter with fluorescence detection capability. The assay was performed using stably-transfected HEK293 cells expressing P-gp, MRP1, or ABCG2 and examining transport of fluorescent substrates in the presence or absence of known inhibitors and compared to results obtained with a flow cytometer. Fold increase in intracellular fluorescence was then calculated for cells incubated with fluorescent substrate in the absence of inhibitor versus in the presence of inhibitor. RESULTS: Fold increase values obtained either with the cell counter or flow cytometer were comparable for cells expressing either MRP1 or ABCG2; slightly higher fold increase values were observed when cells expressing P-gp were read on a flow cytometer compared to the cell counter. DISCUSSION: The assay described provides an inexpensive detection method to aid in the development of novel ABC transporter inhibitors or to characterize potential drug-drug interactions.
INTRODUCTION: The ATP-binding cassette (ABC) transporters P-glycoprotein (P-gp/ABCB1), multidrug resistance-associated protein 1 (MRP1/ABCC1), and breast cancer resistance protein (BCRP/ABCG2) are known to transport a wide range of structurally diverse compounds. Their high level of expression at the blood-brain, maternal-fetal, and blood-testis barriers as well as their purported roles in oral absorption suggests that ABC transporters play important pharmacologic roles. METHODS: We have developed a method to characterize the function and inhibition of ABC transporters using an automated cell counter with fluorescence detection capability. The assay was performed using stably-transfected HEK293 cells expressing P-gp, MRP1, or ABCG2 and examining transport of fluorescent substrates in the presence or absence of known inhibitors and compared to results obtained with a flow cytometer. Fold increase in intracellular fluorescence was then calculated for cells incubated with fluorescent substrate in the absence of inhibitor versus in the presence of inhibitor. RESULTS: Fold increase values obtained either with the cell counter or flow cytometer were comparable for cells expressing either MRP1 or ABCG2; slightly higher fold increase values were observed when cells expressing P-gp were read on a flow cytometer compared to the cell counter. DISCUSSION: The assay described provides an inexpensive detection method to aid in the development of novel ABC transporter inhibitors or to characterize potential drug-drug interactions.
Authors: V V Rao; J L Dahlheimer; M E Bardgett; A Z Snyder; R A Finch; A C Sartorelli; D Piwnica-Worms Journal: Proc Natl Acad Sci U S A Date: 1999-03-30 Impact factor: 11.205
Authors: Jurjen S Lagas; Robert A B van Waterschoot; Vicky A C J van Tilburg; Michel J Hillebrand; Nienke Lankheet; Hilde Rosing; Jos H Beijnen; Alfred H Schinkel Journal: Clin Cancer Res Date: 2009-03-10 Impact factor: 12.531
Authors: Robert W Robey; Suneet Shukla; Elizabeth M Finley; Robert K Oldham; Daryl Barnett; Suresh V Ambudkar; Tito Fojo; Susan E Bates Journal: Biochem Pharmacol Date: 2007-12-14 Impact factor: 5.858
Authors: Serena Marchetti; Nienke A de Vries; Tessa Buckle; Maria J Bolijn; Maria A J van Eijndhoven; Jos H Beijnen; Roberto Mazzanti; Olaf van Tellingen; Jan H M Schellens Journal: Mol Cancer Ther Date: 2008-08 Impact factor: 6.261
Authors: Isa E L M Kuppens; Els O Witteveen; Roxanne C Jewell; Sandra A Radema; Elaine M Paul; Steve G Mangum; Jos H Beijnen; Emile E Voest; Jan H M Schellens Journal: Clin Cancer Res Date: 2007-06-01 Impact factor: 12.531
Authors: Leo Li-Ying Chan; Dee Shen; Alisha R Wilkinson; Wayne Patton; Ning Lai; Eric Chan; Dmitry Kuksin; Bo Lin; Jean Qiu Journal: Autophagy Date: 2012-08-16 Impact factor: 16.016
Authors: Prathusha Kakarla; Madhuri Inupakutika; Amith R Devireddy; Shravan Kumar Gunda; Thomas Mark Willmon; K C Ranjana; Ugina Shrestha; Indrika Ranaweera; Alberto J Hernandez; Sharla Barr; Manuel F Varela Journal: Int J Pharm Sci Res Date: 2016-02-01
Authors: Andrew S Goldsborough; Misty D Handley; Andrés E Dulcey; Kristen M Pluchino; Pavitra Kannan; Kyle R Brimacombe; Matthew D Hall; Gary Griffiths; Michael M Gottesman Journal: J Med Chem Date: 2011-06-24 Impact factor: 7.446
Authors: Lora D Weidner; Sami S Zoghbi; Shuiyu Lu; Suneet Shukla; Suresh V Ambudkar; Victor W Pike; Jan Mulder; Michael M Gottesman; Robert B Innis; Matthew D Hall Journal: J Pharmacol Exp Ther Date: 2015-07-06 Impact factor: 4.030
Authors: Tobie D Lee; Olivia W Lee; Kyle R Brimacombe; Lu Chen; Rajarshi Guha; Sabrina Lusvarghi; Bethilehem G Tebase; Carleen Klumpp-Thomas; Robert W Robey; Suresh V Ambudkar; Min Shen; Michael M Gottesman; Matthew D Hall Journal: Mol Pharmacol Date: 2019-09-12 Impact factor: 4.436
Authors: Manuel Tonigold; Annette Rossmann; Marie Meinold; Michael Bette; Melanie Märken; Katharina Henkenius; Anne C Bretz; Gavin Giel; Chengzhong Cai; Fiona R Rodepeter; Vladimir Beneš; Reidar Grénman; Thomas E Carey; Hermann Lage; Thorsten Stiewe; Andreas Neubauer; Jochen A Werner; Cornelia Brendel; Robert Mandic Journal: J Cancer Res Clin Oncol Date: 2014-06-10 Impact factor: 4.553